TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News Can zilganersen become the first disease-modifying therapy for Alexander disease? Ionis wins FDA breakthrough therapy status for zilganersen in Alexander disease. Find out what this means for rare neurology drug development. byPallavi MadhirajuDecember 2, 2025